Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort

Figure 1

ESPOIR prediction matrix. ESPOIR prediction matrix for use in daily practice in assessing the risk of rapid radiographic progression (RRP; change in vSHS ≥ 5 points at 1 year) in patients with early rheumatoid arthritis in terms of baseline characteristics. ACPA, anti-citrullinated protein antibody; CRP, C-reactive protein (mg/L); vSHS, van der Heijde-modified Sharp score.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us